Skip to main content
Transgene SA (EPA:TNG)
France flag France · Delayed Price · Currency is EUR
0.750
-0.002 (-0.27%)
Apr 28, 2026, 5:35 PM CET

Transgene Revenue

In the year 2025, Transgene had annual revenue of 7.21M EUR with 13.49% growth. Transgene had revenue of 2.63M in the half year ending December 31, 2025, a decrease of -16.13%.

Revenue
7.21M
Revenue Growth
+13.49%
P/S Ratio
28.49
Revenue / Employee
49.72K
Employees
145
Market Cap
205.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.21M857.00K13.49%
Dec 31, 20246.35M-1.55M-19.58%
Dec 31, 20237.90M-2.44M-23.63%
Dec 31, 202210.34M-6.90M-40.00%
Dec 31, 202117.24M7.67M80.08%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sensorion 5.81M
Cellectis 67.79M
ABIONYX Pharma 4.10M
MaaT Pharma 4.52M
Innate Pharma 9.01M
Genfit 65.43M
Valneva SE 174.66M
Adocia 3.85M
Revenue Rankings

Transgene News

More News